CosmeticResearch
Decapeptide-12
Also known as: Lumixyl peptide
A skin-lightening peptide that inhibits melanin production for even skin tone without the toxicity of hydroquinone.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~4 hours (topical)
Typical Dose
Topical (serum formulation)
Administration
Topical
Mechanism of Action
Inhibits tyrosinase enzyme activity to reduce melanin synthesis, providing gradual, non-toxic skin brightening.
Key Research Areas
cosmeticskin lighteningmelanintyrosinase
Frequently Asked Questions
What is Decapeptide-12?▾
A skin-lightening peptide that inhibits melanin production for even skin tone without the toxicity of hydroquinone.
How does Decapeptide-12 work?▾
Inhibits tyrosinase enzyme activity to reduce melanin synthesis, providing gradual, non-toxic skin brightening.
What is the recommended dosage for Decapeptide-12?▾
The typical research dosage is Topical (serum formulation), administered via Topical. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Decapeptide-12?▾
The half-life of Decapeptide-12 is approximately ~4 hours (topical). This affects dosing frequency and timing in research protocols.
Is Decapeptide-12 FDA approved?▾
Decapeptide-12 is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.
Research Disclaimer
The information provided about Decapeptide-12 is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.